Nerissa T. Viola

2.1k total citations
39 papers, 1.2k citations indexed

About

Nerissa T. Viola is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Nerissa T. Viola has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Radiology, Nuclear Medicine and Imaging, 14 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Nerissa T. Viola's work include Radiopharmaceutical Chemistry and Applications (20 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Medical Imaging Techniques and Applications (7 papers). Nerissa T. Viola is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (20 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Medical Imaging Techniques and Applications (7 papers). Nerissa T. Viola collaborates with scholars based in United States, Denmark and Poland. Nerissa T. Viola's co-authors include Robert P. Doyle, Jason S. Lewis, Sean Carlin, Amy E. Rabideau, Jon Zubieta, Heather M. Gibson, Claire E. McCarthy, Michael J. Evans, Kuntal K. Sevak and Jacob L. Houghton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Nerissa T. Viola

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nerissa T. Viola United States 19 563 446 310 191 163 39 1.2k
Wilson B. Edwards United States 23 631 1.1× 414 0.9× 478 1.5× 206 1.1× 186 1.1× 59 1.5k
Ali Azhdarinia United States 25 637 1.1× 408 0.9× 387 1.2× 263 1.4× 115 0.7× 66 1.5k
Jason L.J. Dearling United States 21 597 1.1× 308 0.7× 414 1.3× 190 1.0× 79 0.5× 45 1.2k
Lawrence P. Szajek United States 22 857 1.5× 554 1.2× 290 0.9× 321 1.7× 138 0.8× 57 1.6k
Lihui Wei United States 16 757 1.3× 365 0.8× 304 1.0× 157 0.8× 126 0.8× 37 1.2k
Karen Wong United States 22 693 1.2× 355 0.8× 311 1.0× 261 1.4× 132 0.8× 43 1.2k
Frederik Cleeren Belgium 20 721 1.3× 474 1.1× 204 0.7× 147 0.8× 71 0.4× 47 1.2k
Sarah M. Cheal United States 19 490 0.9× 285 0.6× 320 1.0× 206 1.1× 100 0.6× 36 1.0k
Monica Shokeen United States 17 487 0.9× 310 0.7× 315 1.0× 145 0.8× 163 1.0× 48 1.1k
Maria Paravatou‐Petsotas Greece 19 374 0.7× 296 0.7× 243 0.8× 143 0.7× 91 0.6× 40 954

Countries citing papers authored by Nerissa T. Viola

Since Specialization
Citations

This map shows the geographic impact of Nerissa T. Viola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nerissa T. Viola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nerissa T. Viola more than expected).

Fields of papers citing papers by Nerissa T. Viola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nerissa T. Viola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nerissa T. Viola. The network helps show where Nerissa T. Viola may publish in the future.

Co-authorship network of co-authors of Nerissa T. Viola

This figure shows the co-authorship network connecting the top 25 collaborators of Nerissa T. Viola. A scholar is included among the top collaborators of Nerissa T. Viola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nerissa T. Viola. Nerissa T. Viola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Viola, Nerissa T., et al.. (2023). Imaging Agents for PET of Inflammatory Bowel Disease: A Review. Journal of Nuclear Medicine. 64(12). 1858–1864. 2 indexed citations
2.
Chung, Joon‐Yong, Steve M. Patrick, Seongho Kim, et al.. (2023). Selective ablation of TRA-1-60+ pluripotent stem cells suppresses tumor growth of prostate cancer. Theranostics. 13(7). 2057–2071. 2 indexed citations
3.
Ran, Chongzhao, James Mansfield, Mingfeng Bai, et al.. (2023). Practical Guidance for Developing Small-Molecule Optical Probes for In Vivo Imaging. Molecular Imaging and Biology. 25(1). 240–264. 16 indexed citations
4.
Jacob, Jennifer B., Gerold Bepler, Joyce Reyes, et al.. (2023). Identification of actionable targets for breast cancer intervention using a diversity outbred mouse model. iScience. 26(4). 106320–106320. 3 indexed citations
5.
Jiang, Huailei, Yan Guo, Nerissa T. Viola, et al.. (2023). Automated radiosynthesis of 1‐(2‐[18F]fluoroethyl)‐L‐tryptophan ([18F]FETrp) for positron emission tomography (PET) imaging of cancer in humans. Journal of Labelled Compounds and Radiopharmaceuticals. 66(7-8). 180–188. 4 indexed citations
6.
Chen, Kang, et al.. (2023). Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease. Journal of Nuclear Medicine. 64(11). 1806–1814. 4 indexed citations
7.
Schomburg, Fritz M., et al.. (2022). Evaluation and selection of a lead diabody for interferon-γ PET imaging. Nuclear Medicine and Biology. 114-115. 162–167. 5 indexed citations
9.
Uddin, Md. Hafiz, Mohammed Najeeb Al Hallak, Amro Aboukameel, et al.. (2021). PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to Everolimus. Molecular Cancer Therapeutics. 20(10). 1836–1845. 16 indexed citations
10.
Escorcia, Freddy E., et al.. (2021). Perspectives on metals-based radioimmunotherapy (RIT): moving forward. Theranostics. 11(13). 6293–6314. 35 indexed citations
11.
Spratt, Daniel E., et al.. (2020). Detecting TRA-1–60 in Cancer via a Novel Zr-89 Labeled ImmunoPET Imaging Agent. Molecular Pharmaceutics. 17(4). 1139–1147. 5 indexed citations
12.
Keinänen, Outi, et al.. (2020). Removal of Fc Glycans from [89Zr]Zr-DFO-Anti-CD8 Prevents Peripheral Depletion of CD8+ T Cells. Molecular Pharmaceutics. 17(6). 2099–2108. 5 indexed citations
13.
McCarthy, Claire E., et al.. (2020). In vivo Imaging Technologies to Monitor the Immune System. Frontiers in Immunology. 11. 1067–1067. 53 indexed citations
14.
Nexø, Ebba, et al.. (2019). Systemically Administered Plant Recombinant Holo-Intrinsic Factor Targets the Liver and is not Affected by Endogenous B12 levels. Scientific Reports. 9(1). 12269–12269. 1 indexed citations
15.
Gibson, Heather M., Greg Dyson, Claire E. McCarthy, et al.. (2018). IFNγ PET Imaging as a Predictive Tool for Monitoring Response to Tumor Immunotherapy. Cancer Research. 78(19). 5706–5717. 73 indexed citations
16.
Viola, Nerissa T., et al.. (2018). 89Zr‐ImmunoPET companion diagnostics and their impact in clinical drug development. Journal of Labelled Compounds and Radiopharmaceuticals. 61(9). 727–738. 39 indexed citations
17.
Rosati, Rayna, et al.. (2017). Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen. Journal of Biological Chemistry. 293(4). 1163–1177. 33 indexed citations
18.
Viola, Nerissa T., Samuel L. Rice, Sean Carlin, et al.. (2013). Applying PET to Broaden the Diagnostic Utility of the Clinically Validated CA19.9 Serum Biomarker for Oncology. Journal of Nuclear Medicine. 54(11). 1876–1882. 53 indexed citations
19.
Janjigian, Yelena Y., Nerissa T. Viola, Jason P. Holland, et al.. (2013). Monitoring Afatinib Treatment in HER2-Positive Gastric Cancer with 18F-FDG and 89Zr-Trastuzumab PET. Journal of Nuclear Medicine. 54(6). 936–943. 79 indexed citations
20.
Viola, Nerissa T., et al.. (2008). Targeting the Folate Receptor (FR): Imaging and Cytotoxicity of ReI Conjugates in FR‐Overexpressing Cancer Cells. ChemMedChem. 3(9). 1387–1394. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026